{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:00:00Z","timestamp":1786636800922,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/2230-8210.94250","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T08:36:29Z","timestamp":1332578189000},"page":"20","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenesis and treatment of human immunodeficiency virus lipodystrophy"],"prefix":"10.4103","volume":"16","author":[{"given":"SuyogSubhash","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KarunaBalwant","family":"Ramteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GirishTulsidas","family":"Raparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.94250-1","first-page":"853","volume-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.94250-2","first-page":"1081","volume-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter","author":"Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2230-8210.94250-3","first-page":"543","volume-title":"Randomised, placebo-controlled trial of ritonavir in advanced HIV-1 disease","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.94250-4","first-page":"70","volume-title":"Metabolic complications of antiretroviral therapy","author":"Sweet","year":"2005","journal-title":"Top HIV Med"},{"key":"key-10.4103\/2230-8210.94250-5","first-page":"127","volume-title":"Pathogenesis and treatment of lipodystrophy: What clinicians need to know","author":"Sattler","year":"2008","journal-title":"Top HIV Med"},{"key":"key-10.4103\/2230-8210.94250-6","first-page":"37","volume-title":"HIV Lipodystrophy: A Review","author":"Kravcik","year":"2000","journal-title":"HIV Clin Trials"},{"key":"key-10.4103\/2230-8210.94250-7","first-page":"S141","volume-title":"HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management","author":"Carr","year":"2003","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.94250-8","first-page":"2093","volume-title":"Diagnosis, prediction and natural course of HIV protease inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"key-10.4103\/2230-8210.94250-9","first-page":"1389","volume-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.94250-10","unstructured":"Kingsley L, Smit E, Riddler S, Li R, Chmiel J, Palella F, et al. Prevalence of lipodystrophy and metabolic abnormalities in the Multicenter AIDS Cohort Study (MACS). Program and Abstracts of the 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL; 2001, February 4-8, Abstract 538."},{"key":"key-10.4103\/2230-8210.94250-11","first-page":"37","volume-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.94250-12","first-page":"13","volume-title":"Associated features of lipodystrophy may change significantly with definition criteria.1st IAS Conference on HIV Pathogenesis and Treatment","author":"Belloso","year":"2000","journal-title":"Int Conf AIDS"},{"key":"key-10.4103\/2230-8210.94250-13","first-page":"2","volume-title":"Understanding diabetes in patients with HIV\/AIDS","author":"Kalra","year":"2011","journal-title":"Diabetol Metab Syndr"},{"key":"key-10.4103\/2230-8210.94250-14","first-page":"421","volume-title":"The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations","author":"Shafran","year":"2005","journal-title":"HIV Med"},{"key":"key-10.4103\/2230-8210.94250-15","unstructured":"Polo R, Verdejo M, Gonzalez-Munoz M, et al. Lipodystrophy related to NRT inhibitors in HAART therapy [abstract]. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; Sept 26-29, 1999; San Francisco, CA. Abstract 1302."},{"key":"key-10.4103\/2230-8210.94250-16","unstructured":"Muurahainen N, Santos G, Kleintop M, Kleintop M, Pettit R, Balser J, et al. Gender differences in HIV associated adipose redistribution syndrome (HARS): An update. Seventh Conference on Retroviruses and Opportunistic Infections; 2000; San Francisco, CA. Abstract 26."},{"key":"key-10.4103\/2230-8210.94250-17","first-page":"947","volume-title":"Severe diabetes associated with protease inhibitor therapy","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2230-8210.94250-18","first-page":"2777","volume-title":"Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study","author":"Austin","year":"2000","journal-title":"Circulation"},{"key":"key-10.4103\/2230-8210.94250-19","first-page":"7B","volume-title":"Hypertriglyceridemia as a cardiovascular risk factor","author":"Austin","year":"1998","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/2230-8210.94250-20","first-page":"810","volume-title":"Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS","author":"Mirete","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/2230-8210.94250-21","first-page":"1373","volume-title":"A pilot study of exercise training to reduce trunk fat in adults with HIVassociated fat redistribution","author":"Roubenoff","year":"1999","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.94250-22","doi-asserted-by":"crossref","unstructured":"Aschenbrenner DS. First drug approved for hiv therapy-related lipodystrophy. Am J Nurs. 2011111(4):68-9","DOI":"10.1097\/01.NAJ.0000396562.99317.f7"},{"key":"key-10.4103\/2230-8210.94250-23","first-page":"337","volume-title":"Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: A randomized trial","author":"van","year":"2005","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/2230-8210.94250-24","first-page":"181","volume-title":"Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy","author":"Moyle","year":"2006","journal-title":"HIV Med"},{"key":"key-10.4103\/2230-8210.94250-25","first-page":"581","volume-title":"A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy","author":"Carey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.4103\/2230-8210.94250-26","first-page":"1147","volume-title":"Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients","author":"LoutfyMR,","year":"2007","journal-title":"AIDS"},{"key":"key-10.4103\/2230-8210.94250-27","unstructured":"U.S. Food and Drug Administration. FDA approval of Sculptra for treating facial lipoatrophy. Available from: http:\/\/www.fda.gov\/ForConsumers\/ ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm125007.Htm [Last cited on 2011 Jun 12]."},{"key":"key-10.4103\/2230-8210.94250-28","unstructured":"U.S. Food and Drug Administration. FDA approves Radiesse for treating facial lipoatrophy. Available from: http:\/\/www.fda.gov\/ForConsumers\/ ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm124413.htm [Last cited on 2011 Jun 12]."}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:01:11Z","timestamp":1786633271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2230-8210.94250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"alternative-id":["94250"],"URL":"https:\/\/doi.org\/10.4103\/2230-8210.94250","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}